| Product Code: ETC7652881 | Publication Date: Sep 2024 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Haemophilia Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Haemophilia Market - Industry Life Cycle |
3.4 Israel Haemophilia Market - Porter's Five Forces |
3.5 Israel Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Israel Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Israel Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 Israel Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Israel Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Israel Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Haemophilia Market Trends |
6 Israel Haemophilia Market, By Types |
6.1 Israel Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Israel Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Israel Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 Israel Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 Israel Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 Israel Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 Israel Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 Israel Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Israel Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Israel Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 Israel Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 Israel Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 Israel Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 Israel Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Israel Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 Israel Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 Israel Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Israel Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Israel Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Israel Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Israel Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Israel Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Israel Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Israel Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Haemophilia Market Import-Export Trade Statistics |
7.1 Israel Haemophilia Market Export to Major Countries |
7.2 Israel Haemophilia Market Imports from Major Countries |
8 Israel Haemophilia Market Key Performance Indicators |
9 Israel Haemophilia Market - Opportunity Assessment |
9.1 Israel Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Israel Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Israel Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 Israel Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Israel Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Israel Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Haemophilia Market - Competitive Landscape |
10.1 Israel Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 Israel Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here